Brainsway Ltd. (BRSYF)
Alternate day dTMS combined with SSRIs for chronic treatment resistant depression: A prospective multicenter study
Alternate day dTMS combined with SSRIs for chronic treatment resistant depression: A prospective multicenter study
📈 **POSITIVE** • Medium confidence analysis (71%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical